![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 08, 2022 4:08:42 PM
OTCShotCaller
08:05 AM
$RGBP
- Here's what to expect NEXT! You can bet that the recent CNN Interview with Oncologist Dr. Andrea Cercek at Sloan Kettering Cancer Center in New York who conducted the clinical trials on 14 patients with colon cancer by using the check point inhibitor Monoclonal Antibody Dostarlimab with 100% remission in ALL patents within 24 weeks, immediately went GLOBAL! It's the FIRST TIME EVER in the clinical practice of Oncology worldwide! This breakthrough represents the "Paradigm Shift" I've discussed here many times that represents the Future of Medicine, and NOW it's become an astonishing reality! Being a clinical trials physician for 30 years within the Big Pharma sector, I knew this was inevitable! What's also inevitable is every Big Pharma on the planet has heard this news by now and will be racing to grab Check Point Inhibitor Patents from any Biohparmas that have them, in particular those based on mRNA Vaccine, like RGBP. Don't be surprise if Dr Koos gets a call from Eli Lilly!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM